A disease no parent wants to think about
A newborn arrives. Small. New. Fragile in ways it is hard to put into words.
Most infections in this life stage are handled well by modern medicine. But a few can turn devastating quickly. Herpes simplex virus (HSV) infection of the brain, called neonatal HSV encephalitis, is one of them.
It is rare. But when it strikes, it is deadly without fast treatment.
Herpes viruses are everywhere in the adult population. HSV-1, which causes cold sores, affects most adults. HSV-2, usually a genital virus, affects a smaller but still substantial share.
Babies can pick up either virus during birth or shortly after. In most cases, the infection stays local and manageable. In some, it spreads to the brain. That is when the crisis begins.
Traditionally, doctors watched for a skin rash as a warning sign. But newer research shows many babies with HSV brain infection never develop that rash, or develop it late. Without the classic clue, diagnosis can be delayed, and delays cost lives.
Older testing for HSV brain infection relied on polymerase chain reaction (PCR) on cerebrospinal fluid. It is accurate but not perfect. Sometimes it misses early cases.
Newer testing uses metagenomic next-generation sequencing (mNGS). This technique reads every piece of genetic material in a sample at once, not just what you already think to look for. It can catch infections PCR misses.
This study compared how both methods performed in real newborns.
How it works, in plain English
Think of PCR like looking for a specific key in a messy drawer by describing exactly what it looks like. If the key is there, you find it. If it is hiding under something or at the wrong angle, you might miss it.
Metagenomic sequencing is like dumping the drawer onto a table and photographing every single item. Then a computer sorts through the pile and flags whatever keys match known patterns. Nothing hides.
For a virus in cerebrospinal fluid, that difference matters. A small amount of HSV DNA can slip past PCR if the timing or sample is off. Sequencing finds it anyway.
The study snapshot
Researchers at a children's hospital in China reviewed 14 newborns diagnosed with HSV brain infection between 2016 and 2024.
The median age at diagnosis was 26 days. That is later than classical teaching suggests, which focuses on the first two weeks of life.
They examined how each infection was detected, what tests worked, and how children fared.
Here's what they found
Symptoms were often nonspecific. Fever was common. So were seizures. In 13 of 14 cases, some form of neurological symptom (seizure, lethargy, irritability, altered mental state) was present.
The classic skin rash was notably absent in many cases. That makes the diagnosis harder, because doctors cannot rely on visible clues.
Genetic testing was key. HSV-DNA was detected in 13 of 14 cases by either PCR or metagenomic sequencing. PCR found it in 9 cases, with 2 requiring a second test to catch. Metagenomic sequencing found it in all 6 cases where it was used, on the first test.
That speed advantage can matter in real time.
Brain MRI showed early swelling that later progressed to multiple cystic areas where brain tissue had been destroyed. Video EEG often showed abnormal electrical activity in the temporal lobes.
But here is the catch.
Outcomes were serious. All 14 babies received acyclovir, the standard antiviral. Seven discontinued treatment early. One was transferred for eye problems. Only six improved and were discharged.
HSV brain infection leaves deep marks even when treated promptly. Brain tissue damaged by the virus does not fully regenerate.
How the researchers read it
The authors emphasize early CSF testing and prompt antiviral therapy as the keys to better outcomes. They advocate for metagenomic sequencing especially when conventional PCR is negative but the clinical picture fits.
They also highlight that HSV encephalitis in newborns does not always look the way textbooks describe. No rash, late onset, and nonspecific symptoms should not rule it out.
If you are a parent of a newborn and notice any concerning symptoms, act quickly. Fever, seizures, persistent lethargy, poor feeding, or abnormal movements all deserve urgent evaluation.
Do not assume you would see a rash if something serious were happening. Many dangerous newborn infections, including HSV brain infection, can hide without visible skin changes.
For pregnant women, discuss your HSV history with your obstetrician. If you have active genital HSV at delivery, a cesarean section may reduce transmission risk. Antiviral suppression in late pregnancy can also lower risk.
The limits
This was a single-center study of 14 cases. Patterns could differ in other hospitals or populations.
The study focused on diagnosed cases. Babies who died before diagnosis or were diagnosed after discharge are not included.
Long-term neurological outcomes were not tracked. Even survivors of HSV encephalitis often have lasting effects, which this study does not quantify.
Wider use of metagenomic sequencing in newborn intensive care units could help catch these cases sooner. So could sharper clinical criteria that do not depend on the presence of a rash.
Research into better antivirals and brain-protective treatments is ongoing. For the rare babies affected, any advance in speed or depth of treatment makes a real difference.
